Loading
NeuPath Health Inc. Stock: price and insider trades · Canada
CA·Mcap CA$30.8M
NeuPath Health Inc.: what insiders have been doing
NeuPath Health Inc. is a listed company. Its directors and officers file their transactions with SEDI. In the past year (18 October 2025 to 18 October 2026), 61 filings came from 7 insiders.
The flow runs one way only: 2 insiders bought (2 purchases totalling €15k) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 senior executives. The largest single trade was a purchase of €10k by Zygouras, Zaffirios, published on 23 September 2026, equal to 0.052% of the market capitalisation.
The last purchase on record was published on 23 September 2026, which is 24 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 21 days. That lag is the time during which only the insider knows about the trade.
With 61 filings in twelve months, the company is more active than the median of 11 filings across the 2,121 companies we follow on the same exchange. Since 2026, the database holds 2 purchases and no sales by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
61
Thresholds
n/a
Buy Volume
€14,714
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleStephen Lemieux1 buy
Zaffirios Zygouras1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,717 of 24,148 companies
38.9
score / 100
Value47
Quality31
FCF yld9.5%
Earn yld-2.2%
EV/EBITDA14.8x
ROE7.2%
Gross mgn19%
Net mgn-0.8%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.54
Analyst consensus
2 analysts1.50/5
CA$0.68Target CA$0.82(+51%)CA$0.95
Income statement
RevenueCA$87.2M
Gross profitCA$16.6M19% margin
EBITDACA$3.1M4% margin
Net income-CA$717k1.5% margin
Valuation
PER (trailing)27.0x
PER (forward)5.4x
P/Book1.3x
Beta0.91
Balance sheet & cash
Market capCA$30.8M
Total debtCA$13.1M
Free Cash FlowCA$3.1M
Debt / Equity56%
Profitability & ownership
ROE7.2%
ROA3.3%
% insiders2.9%
% institutions10.8%
Last declaration on 2 October 2026
Declarations61 total
63,500 sharesCommon SharesTSXSEDI:4785279
5,000 shares@ CA$0.530.0080% mcap1.6% of flowCommon SharesTSXSEDI:4785273
7,500 shares@ CA$0.53730.012% mcap2.4% of flowCommon SharesTSXSEDI:4785268
7,500 shares@ CA$0.520.012% mcap2.3% of flowCommon SharesTSXSEDI:4785261
7,500 shares@ CA$0.530.012% mcap2.3% of flowCommon SharesTSXSEDI:4785253
7,500 shares@ CA$0.540.012% mcap2.4% of flowCommon SharesTSXSEDI:4785248
7,500 shares@ CA$0.550.012% mcap2.4% of flowCommon SharesTSXSEDI:4785238
7,500 shares@ CA$0.550.012% mcap2.4% of flowCommon SharesTSXSEDI:4785233
500 shares@ CA$0.550.0008% mcap0.2% of flowCommon SharesTSXSEDI:4785229
4,000 shares@ CA$0.550.0066% mcap1.3% of flowCommon SharesTSXSEDI:4785225
1,500 shares@ CA$0.550.0025% mcap0.5% of flowCommon SharesTSXSEDI:4785221
7,500 shares@ CA$0.540.012% mcap2.4% of flowCommon SharesTSXSEDI:4785219
12,500 shares@ CA$0.570.022% mcap100.0% of flowCommon SharesTSXSEDI:4780708
Canonical exit: 22 Dec 2026 (T+90)
30,000 shares@ CA$0.550.052% mcap8.4% of flowCommon SharesTSXSEDI:4780633
Canonical exit: 22 Dec 2026 (T+90)
57,500 sharesCommon SharesTSXSEDI:4769851
5,000 shares@ CA$0.600.0094% mcap2.2% of flowCommon SharesTSXSEDI:4769850
7,500 shares@ CA$0.600.014% mcap3.3% of flowCommon SharesTSXSEDI:4769849
7,500 shares@ CA$0.630.015% mcap3.5% of flowCommon SharesTSXSEDI:4769848
7,500 shares@ CA$0.610.014% mcap3.4% of flowCommon SharesTSXSEDI:4769847
7,500 shares@ CA$0.610.014% mcap3.3% of flowCommon SharesTSXSEDI:4769845
7,500 shares@ CA$0.59330.014% mcap3.3% of flowCommon SharesTSXSEDI:4769843
7,500 shares@ CA$0.620.015% mcap3.4% of flowCommon SharesTSXSEDI:4769842
7,500 shares@ CA$0.620.015% mcap3.4% of flowCommon SharesTSXSEDI:4769841
53,500 sharesCommon SharesTSXSEDI:4759848
5,000 shares@ CA$0.640.010% mcap2.3% of flowCommon SharesTSXSEDI:4759846
25 of 61 declarations
About NeuPath Health Inc.
NeuPath Health Inc. is a Canadian healthcare company focused on the treatment of chronic pain. It primarily operates on the Toronto Stock Exchange (XTSE).
